SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Lal PathLabs’ arm gets nod for signing binding term sheet

01 Oct 2019 Evaluate

Dr. Lal PathLabs’ wholly owned subsidiary -- Pathlabs Unifiers has received approval for signing binding term sheet for acquisition of 70% equity stake in a ‘New Company to be incorporated’. The Board of Director of Pathlabs Unifiers at their meeting held on October 01, 2019, approved the same.

According to the Term Sheet, the ‘New Company to be incorporated’ will house the business of Amins Pathology Referral Laboratory, a Proprietorship concern of Dr. Ripal Padmani and engaged in Pathology Business in Vadodara in Gujarat, before Pathlabs Unifiers buys 70% stake in it.

Dr. Lal Pathlabs is recognized as a centre of innovation and a premier clinical pathology laboratory. It is the largest and most respected diagnostic service provider in the country.

Dr. Lal Pathlabs Share Price

1403.15 -8.60 (-0.61%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×